PHARMA INFLUENCERS | NEWSLETTERS | WEBINARS

Christopher Horne

How to use psychology to create stronger emotional connections to your brand

How to use psychology to create stronger emotional connections to your brand By Christopher Horne INTRODUCTION Psychology is ‘hot’ when it comes to pharma marketing. And for...

THE RAPIDLY EVOLVING WORLD OF MARKET RESEARCH – HELPING COMPANIES TO BECOME MORE CUSTOMER-CENTRIC THAN EVER

By Christopher Horne, Director at Research Engine Limited Marketers rely on great customer insights to inform winning marketing plans and programmes. Professionals know that the only...

Recent Featured Articles

A Q&A Session with SpendEdge’s Thought Leader on the Current Pharmaceutical Industry Against the Backdrop of the Corona Virus Epidemic

LONDON--(BUSINESS WIRE)--SpendEdge, a leading procurement intelligence firm, has recently announced the completion of its latest Q&A article on the rising complexities and the ways...

Vifor Pharma acquires Priority Review Voucher

ST GALLEN, Switzerland--(BUSINESS WIRE)--Regulatory News: Vifor Pharma today announced that it has agreed to purchase a US Food and Drug Administration (FDA) priority review voucher...

Life Science Workforce Pipeline Sustainability Among Topics To Be Discussed at the MichBio BioTalent Summit

ANN ARBOR, Mich.--(BUSINESS WIRE)--MichBio, the Michigan Bioscience Industry Association, will hold a BioTalent Summit on March 16th focused on bringing together bio-industry stakeholders to...

Sensorion Receives Ethics Committee Approval to Include New Military Sites in SENS-401 Phase 2 study

MONTPELLIER, France--(BUSINESS WIRE)--Regulatory News: Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotech company which specializes in the development of novel therapies to restore, treat and...

Newron Expands Global Rett Syndrome Burden of Illness Survey Outreach to Europe and Australia

MILAN & MORRISTOWN, N.J.--(BUSINESS WIRE)--Newron Pharmaceuticals S.p.A. (“Newron”) (SIX: NWRN, XETRA: NP5), a biopharmaceutical company focused on the development of novel therapies for patients...